Ann Arbor, MI · Founded 2011 · Privately Held (backing)
Operator of a biopharmaceutical company intended to protect and improve patients' vision with various retinal diseases and conditions. ONL Therapeutics is based in Ann Arbor, MI and was founded in 2011. It has raised $133 million across 10 recorded rounds; the latest was a $60 million later-stage round in Sep 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$132.5M
Last round
Later Stage VC
Sep 2024
Team — not yet on record
No current team members for ONL Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ONL Therapeutics with a free account
·The complete investor list: 26 names
·Watch ONL Therapeutics: the Monday email on marks, rounds and moves
